Nanocarriers for anticancer drugs: Challenges and perspectives
Open Access
- 22 April 2022
- journal article
- review article
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 29 (6) , 103298
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Classification of stimuli–responsive polymers as anticancer drug delivery systemsDrug Delivery, 2014
- Transferrin-tailored solid lipid nanoparticles as vectors for site-specific delivery of temozolomide to brainJournal of Nanoparticle Research, 2013
- Conjugation of Functionalized SPIONs with Transferrin for Targeting and Imaging Brain Glial Tumors in Rat ModelPLOS ONE, 2012
- Transferrin-Modified c[RGDfK]-Paclitaxel Loaded Hybrid Micelle for Sequential Blood-Brain Barrier Penetration and Glioma Targeting TherapyMolecular Pharmaceutics, 2012
- Targeted Delivery of NanomedicinesISRN Pharmacology, 2012
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdvanced Drug Delivery Reviews, 2011
- Tumor delivery of macromolecular drugs based on the EPR effectAdvanced Drug Delivery Reviews, 2011
- PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumorsBiomaterials, 2011
- Alginate/Chitosan Nanoparticles are Effective for Oral Insulin DeliveryPharmaceutical Research, 2007
- PLA Nano‐ and Microparticles for Drug Delivery: An Overview of the Methods of PreparationMacromolecular Bioscience, 2007